BGMS - Bio Green Med Solution Short-Term Debt to Capital
Bio Green Med Solution Inc (BGMS) holds significant authority within the oncology community due to the development of high-precision tools for controlling tumor cell division. The company's revenues rely on partnerships with pharmaceutical behemoths and the commercialization of innovative drugs. The current figure is 0.00. This daily price chart, provided for analytical convenience, complements the profile of a brand renowned for the safety and selectivity of its therapeutic molecules.
Summary analytical data breakdowns for cyclacel.com (BGMS)
This ratio assesses the dependence of Bio Green Med Solution Inc (BGMS) on liabilities maturing within one year relative to its equity, determining the balance between financial stability and the use of leverage. By analyzing this short-term debt-to-equity chart, an investor can evaluate the liquidity of Bio Green Med Solution Inc (BGMS), which is critical for sustaining costly developments in high-precision targeted oncology therapy.